ludi therapeutics is a new monaco biotech company focused on treating sports-related injuries.

---

MANAGING DIRECTOR & GLOBAL SPORTS VENTURES

Juli has 15 years of experience in the sports and entertainment business, starting at Cirque de Soleil and including FC Barcelona, where he led the Global Sponsorship department. FC Barcelona is the most followed club in the world and was the first to reach 1B EUR in revenue. Juli has a multi-sport background including FIFA Beach Soccer and FIBA. In his most recent role, he managed the Commercial and Marketing department of AS Monaco FC. His vast experience has enabled Juli to develop solid sport relationships on an international level.

FOUNDER & CEO

Cindy uniquely combines business experience with 15 years of expertise in drug discovery. Her most recent position was within the Business Development Team at Pharmaron. Passionate about innovative drug discovery technologies, she has worked in US biotech companies (Warp Drive Bio, ForteBio) and consulted for Third Rock Ventures. Cindy hold a Ph.D. in Biophysics (France) and an M.B.A specialized in Venture Capital and M&A (Monaco). 

FOUNDER 

Guillaume is a project leader in therapeutics at the Broad Institute of MIT & Harvard with 15+ years of experience in pharmaceutical sciences. Focusing on drug discovery, he has worked in numerous therapeutic areas with world class institutions including MD Anderson Cancer Center, UCSF and early stage biotechs. Guillaume hold a Pharm.D.  and a Ph.D. in structural biology. His postdoctoral research was undertaken at UCSF with Medicine Nobel Laureate Stanley Prusiner.

COO 

Fabrice worked as a research scientist in medtech for more than 12 years in top-tier institutes worldwide. He was deeply involved in the entrepreneurial scene leading to multiple startup successes including one IPO. He setup from scratch and led MonacoTech, the first and only incubator program in Monaco. In less than a year, he created a portfolio of 12 hand – selected companies valued over 100M€. 

CFO

Elena is an entrepreneur, business angel, mentor and interim CFO. She has 14 years of international financial reporting experience and management consulting roles, including 7 years of Interim CFO roles in Switzerland for public and VC-backed private companies. She contributed to 15+ private equity deals that have deployed $100 million. As Business Angel and business mentor she advised over 50 clients on raising $100 million in equity in the healthcare, consumer, media, software, energy, and industrial sectors. She enjoys working with founders of early stage and mature small-cap firms.

COMMUNICATIONS

Céline is a marketing and business

development specialist with over

20 years of experience working

for Fortune 500 companies and

start ups in Europe and the US. She

thrives on identifying and realising

opportunities to grow brands and

companies. Her passion for creative

communications, compelling

design and digital innovation

makes her the adept at applying

creativity to achieve business goals.

Scott has over 30 years’ experience in corporate finance and strategic initiatives for a range of clients, with extensive cross-border transaction experience in Europe, North America, Asia and the Middle East. He was in the International Capital Markets group at Morgan Stanley & Co in New York and Paris and previously held positions within corporate finance, fixed income and equity sales and syndication at LF Rothschild and the US offices of the OECD in New York.

Dr. Malmgren is an economist and an award-winning author who served former President in the White House and on the National Economic Council. She combines her interest in the economy, technology, and geopolitics to found tech companies and to advise investors and policymakers. She is a partner of The Monaco Foundry, a startup incubator and a Senior Advisor to Avonhurst, a solutions-oriented legal and consulting firm. She is the Chairman of Datifly which advices on the drone industry. She has been the Chairman of The BSI subcommittee on drone manufacturing standards (ACE 22) She co-founded a firm in the drone space of a firm in the drone/autonomy space that won a 2020 CogX award and the 2020 National Technology Award.

Ken was Senior Advisor to the Saudi Arabian Minister of Health, helping to design the new delivery model and implementation of the Saudi Healthcare Transformation Programme, Vision 2030. Previously, Ken was Vice Chairman of UBS’s global health advisory advising among others GSK, HCA, Swedish Government, UK Government, Arcadia, Blackstone, Mubadala, TPG, Dell, and BP. Prior to that Ken was Commercial Director General of the Department of Health and National Health Service initiating privatisation-based NHS reforms.